Insider Activity of MILLIGAN JOHN F
Biography of MILLIGAN JOHN F
Dr. John F. Milligan, age 58, has made significant contributions to the biotechnology and pharmaceutical industries throughout his impressive career. He holds a Ph.D. in Biochemistry from the University of Illinois and a B.A. in Chemistry from Ohio Wesleyan University. Milligan's career is marked by an extraordinary tenure at Gilead Sciences, Inc., where he joined in 1990 and ascended through various pivotal roles. At Gilead, Milligan served as President and COO before being appointed CEO in 2016, steering the company through a period of remarkable growth and innovation. Under his leadership, he oversaw the development and commercialization of transformative therapies in HIV and hepatitis C, significantly impacting global health. His strategic vision propelled Gilead to the forefront of biopharmaceutical research and development, securing its reputation as a leader in the field. In addition to his influential work at Gilead, Milligan is an insider at 4D Molecular Therapeutics, Inc. His expertise in therapeutic development and strategic management has been instrumental in advancing the company's mission to create targeted gene therapies. His tenure in these prominent organizations underscores his dedication to pioneering health solutions and his role as a trailblazer in biotechnology. Milligan's career is marked by a blend of scientific acumen and executive leadership, solidifying his legacy in the industry.